These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18492905)

  • 41. [Percutaneous radiofrequency ablation (PRFA) for hepatocellular carcinoma].
    Osaki Y; Kimura T; Kita R; Kokuryu H; Takamatsu S; Shimizu T
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1640-5. PubMed ID: 11707998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence.
    Murakami T; Ishimaru H; Sakamoto I; Uetani M; Matsuoka Y; Daikoku M; Honda S; Koshiishi T; Fujimoto T
    Cardiovasc Intervent Radiol; 2007; 30(4):696-704. PubMed ID: 17497071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma.
    Lam VW; Ng KK; Chok KS; Cheung TT; Yuen J; Tung H; Tso WK; Fan ST; Poon RT
    J Am Coll Surg; 2008 Jul; 207(1):20-9. PubMed ID: 18589357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transjugular intrahepatic portosystemic shunt occlusion via modified pringle maneuver for radiofrequency ablation of nearby tumor.
    Pua U; Punamiya S
    J Vasc Interv Radiol; 2012 Apr; 23(4):563-5. PubMed ID: 22464718
    [No Abstract]   [Full Text] [Related]  

  • 45. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
    Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
    J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients--mathematic model, overlapping mode, and electrode placement process.
    Chen MH; Yang W; Yan K; Zou MW; Solbiati L; Liu JB; Dai Y
    Radiology; 2004 Jul; 232(1):260-71. PubMed ID: 15166323
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of ablative margin on local tumor progression and survival in patients with HCC ≤4 cm after laser ablation.
    Francica G; Petrolati A; Di Stasio E; Pacella S; Stasi R; Pacella CM
    Acta Radiol; 2012 May; 53(4):394-400. PubMed ID: 22393158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiofrequency ablation of problematically located hepatocellular carcinoma: tailored approach.
    Chen MH; Yang W; Yan K; Hou YB; Dai Y; Gao W; Zhang H; Wu W
    Abdom Imaging; 2008; 33(4):428-36. PubMed ID: 17639375
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
    Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
    Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Ultrasound-guided percutaneous composite thermal ablation technique in treatment of medium and large hepatocellular carcinoma].
    Yin XY; Xie XY; Lü MD; Chen JW; Xu HX; Xu ZF; Liu GJ; Huang B
    Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1029-32. PubMed ID: 15498312
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey.
    Pompili M; Saviano A; de Matthaeis N; Cucchetti A; Ardito F; Federico B; Brunello F; Pinna AD; Giorgio A; Giulini SM; De Sio I; Torzilli G; Fornari F; Capussotti L; Guglielmi A; Piscaglia F; Aldrighetti L; Caturelli E; Calise F; Nuzzo G; Rapaccini GL; Giuliante F
    J Hepatol; 2013 Jul; 59(1):89-97. PubMed ID: 23523578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study.
    Chow DH; Sinn LH; Ng KK; Lam CM; Yuen J; Fan ST; Poon RT
    J Surg Oncol; 2006 Dec; 94(7):565-71. PubMed ID: 17048238
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Risk factors of survival for recurrent hepatocellular carcinoma treated by percutaneous radiofrequency ablation].
    Liang HH; Xue P; Chen MS; Chen D; Peng HP; Li JQ
    Zhonghua Wai Ke Za Zhi; 2010 May; 48(10):738-42. PubMed ID: 20646488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?
    Shibata T; Isoda H; Hirokawa Y; Arizono S; Shimada K; Togashi K
    Radiology; 2009 Sep; 252(3):905-13. PubMed ID: 19567647
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined hepatectomy and radiofrequency ablation for multifocal hepatocellular carcinomas: long-term follow-up results and prognostic factors.
    Choi D; Lim HK; Joh JW; Kim SJ; Kim MJ; Rhim H; Kim YS; Yoo BC; Paik SW; Park CK
    Ann Surg Oncol; 2007 Dec; 14(12):3510-8. PubMed ID: 17653800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatocellular carcinoma: percutaneous radiofrequency ablation using expandable needle electrodes and the double-insertion technique.
    Shirato K; Morimoto M; Tomita N; Kokawa A; Sugimori K; Saito T; Tanaka K
    Hepatogastroenterology; 2002; 49(48):1481-3. PubMed ID: 12397712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Percutaneous radiofrequency ablation therapy of hepatocellular carcinoma using multitined expandable electrodes: comparison of subcapsular and nonsubcapsular tumors.
    Cho YK; Rhim H; Ahn YS; Kim MY; Lim HK
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S269-74. PubMed ID: 16632687
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Application of ultrasound-guided percutaneous radiofrequency ablation in treatment of liver cancer].
    Xie XY; Lü MD; Yin XY; Chen JW; Shen Q; Xu HX; Huang P; Huang JF
    Zhonghua Wai Ke Za Zhi; 2003 Jan; 41(1):23-6. PubMed ID: 12760752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Planning sonography to assess the feasibility of percutaneous radiofrequency ablation of hepatocellular carcinomas.
    Rhim H; Lee MH; Kim YS; Choi D; Lee WJ; Lim HK
    AJR Am J Roentgenol; 2008 May; 190(5):1324-30. PubMed ID: 18430851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.